Clinical significance of human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the risk of ovarian malignancy algorithm (ROMA), and Copenhagen index (CPH-I) for the diagnosis of endometrial carcinoma
Introduction: Endometrial carcinoma (EC) is the most common gynecological cancer among women, and in more than 90% of cases, the initial manifestation of the disease is postmenopausal bleeding. Unfortunately, despite early diagnosis and treatment, EC often recurs. Among the many serum tumor markers...
Saved in:
| Main Authors: | Vesselina Koleva, Sevim Shefket, Snezhana Stoencheva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-02-01
|
| Series: | Folia Medica |
| Online Access: | https://foliamedica.bg/article/143849/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison Between HE4, CA-125, and Combination of Both HE4 and CA-125 as Tumor Markers for Epithelial Ovarian Carcinoma Patients
by: PUNGKY MULAWARDHANA, et al.
Published: (2012-04-01) -
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
by: Karin Abbink, et al.
Published: (2018-02-01) -
The Diagnostic Value of 3.0 T Magnetic Resonance Imaging Combined with Carbohydrate Antigen 125 and Human Epididymis Protein 4 in Epithelial Ovarian Cancer
by: Tie Cao, et al.
Published: (2024-11-01) -
Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer
by: Nabil Abdalla, et al.
Published: (2017-01-01) -
Carbohydrate Antigen-125
by: Vijay U. Rao, MD, PhD, et al.
Published: (2025-07-01)